Stock screener

ETON

Conviction 72HealthcareScan · Mon, Aug 10, 2026
ETON$43.63-2.17%
ResistanceSupportVol 14Insider sell
63 bars
4
2
2
2
3
Vol MA14 509.61K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Eton Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.etonpharma.com ↗
Price43.63
Change-2.17%
Gap-0.58%
Rel volume0.97×
Avg volume566.76K
Avg $ vol24.78M
SMA 2043.70
SMA 5037.44
SMA 20024.45
Price vs 50+16.53%
Price vs 200+78.44%
MA stackbullish
50/200 cross—
Supertrendup · 40.87
RSI (14)55
MACD hist-0.45
MACD crossbear · 2d
Stoch %K / %D19 / 40
ADX (14)38
+DI / −DI27 / 18
RSI divergence—
MACD divergence—
ATR %+5.35%
ADR %5.79%
52w high49.03
52w low14.35
From 52w high-11.01%
Above 52w low+204.04%
New 52w highNo
SqueezeOff
Bollinger width29.17%
%B0.49
Donchian pos51.09%
Donchian high50.18
Donchian low36.79
AVWAP (52w high)46.42
vs AVWAP high-6.01%
AVWAP (52w low)30.25
vs AVWAP low+44.22%
OBV trendUp
Chaikin MF (20)0.16
Today vs 20d0.97×
Avg vol (14d)509.61K
Avg vol (20d)566.76K
Avg $ vol (20d)24.78M
Market cap1.2B
RS 3m (vs SPY)+38.08%
RS 6m (vs SPY)+196.69%
RS line new highNo
Trend template8/8
Technical rank88.7
1 week-3.35%
1 month+19.18%
3 months+47.15%
6 months+195.60%
1 year+185.91%
YTD+168.33%
P/E-259.75
P/B39.04
P/S14.95
P/FCF117.27
EPS-0.1700
Div yield—
ROE-15.03%
ROA-4.71%
Debt/Eq0.91
Current1.21
EV/EBITDA—
Gross margin53.46%
Net margin-5.75%
Rev growth104.94%
EPS growth-20.35%
Price target54.75
Target upside25.49%
Analyst ratingBuy
Institutional72.53%
Ent. value1.2B
Revenue24.27M
Net income1.55M
Gross profit14.73M
Free cash flow10.19M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out27.39M
Employees44
ListedWed, Nov 14, 2018
Free float24.33M
Float %88.9%
Short interest1.23M
Days to cover3.0d
Short volume48.7%
Squeeze score31 / 100
Next earningsThu, Aug 13, 2026 · after (3d)
EPS forecast$0.13 · 2 est
Last EPS vs est$0.05 vs $0.10
Last surprise-50.0% miss
Setup gradeB
Conviction72 / 100
Pattern quality—
Tech rank88.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance49.29
Support33.22
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ETON

All disclosures →
No recent disclosed trades by Congress in ETON. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ETON · 1 buy · 9 sells

InsiderSideShares
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-14
Sell15K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-14
Sell13.31K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-14
Sell15K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-14
Sell13.31K
Krempa David
Chief Business Officer · Common Stock · 2026-07-12
Exercise10K
Krempa David
Chief Business Officer · Restricted Stock Units · 2026-07-12
Exercise10K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-07
Sell20K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-07
Sell6.68K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-06
Sell10K
Opaleye Management Inc.
10% owner · Common Stock, par value $0.001 per share · 2026-07-02
Sell25K

SEC filings

EDGAR filings in ETON · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.